1. Enhancement of the antitumor effect of 5-fluorouracil with modulation in drug transporters expression using PI3K inhibitors in colorectal cancer cells
   Sherien M. El-Daly et al, 2023, Life Sciences CrossRef
2. Polycaprolactone-based Nanocarriers Containing 5-fluorouracil as a Therapeutic Guided Drug Delivery Approach for Enhancing Anticancer Activity
   Samaneh Mohammadian et al, 2023, Current Cancer Drug Targets CrossRef
3. Mannose Inhibits the Pentose Phosphate Pathway in Colorectal Cancer and Enhances Sensitivity to 5-Fluorouracil Therapy
   Sadaf Al Hadeethi et al, 2023, Cancers CrossRef
4. 5-fluorouracil treatment of patient-derived scaffolds from colorectal cancer reveal clinically critical information
   Simona Salerno et al, 2022, Journal of Translational Medicine CrossRef
5. The critical role of circular RNAs in drug resistance in gastrointestinal cancers
   Sadra Samavarchi Tehrani et al, 2023, Medical Oncology CrossRef
6. scFv biofunctionalized nanoparticles to effective and safe targeting of CEA-expressing colorectal cancer cells
   Maria José Silveira et al, 2023, Journal of Nanobiotechnology CrossRef
7. Resveratrol as sensitizer in colorectal cancer plasticity
   Aranka Brockmueller et al, 2024, Cancer and Metastasis Reviews CrossRef
8. Trapping of 5-Fluorodeoxyuridine Monophosphate by Thymidylate Synthase Confers Resistance to 5-Fluorouracil
   Chinatsu Kurasaka et al, 2022, ACS Omega CrossRef
9. Anticancer sensitivity and biological aspect of 5-fluorouracil-resistant human colorectal cancer HCT116 cells in three-dimensional culture under high- and low-glucose conditions
   Chinatsu Kurasaka et al, 2024, Nucleosides, Nucleotides & Nucleic Acids CrossRef
10. In Vitro Assessment of the Synergistic Effect of Aspirin and 5-Fluorouracil in Colorectal Adenocarcinoma Cells
    Monica Susan et al, 2023, Current Oncology CrossRef
11. Regulation of thymidylate synthase: an approach to overcome 5-FU resistance in colorectal cancer
    Adarsh Kumar et al, 2022, Medical Oncology CrossRef
12. The mechanism underlying resistance to 5‑fluorouracil and its reversal by the inhibition of thymidine phosphorylase in breast cancer cells
    Ryutaro Mori et al, 2022, Oncology Letters CrossRef